What isn't measured isn't treated.
Most leaders get one standard panel and a rushed appointment, then hear that everything is fine. “Normal” labs are not the same as high performance, and that gap is where I work. I treat longevity as an engineering problem: measure early, act early.
Aging Isn’t Something You Wait Out
You have more leverage over how you age than anyone has told you. Most of the risks that matter respond to early, deliberate work: diagnostics run sooner, intervention started sooner, habits held for decades. My role is to help you use that leverage on purpose, and to be candid about where the evidence runs thin.
Test, Treat, Retest
You can't personalize what you haven't measured. You can't prevent what you haven't personalized. And you can't know it worked without measuring again.
Establish the Baseline
Know the biology before you touch it.
→Fit the Person
Build the strategy around your biology and your ambitions.
→Act Early
Move on the risks before they cost you performance.
→Read the Data
Stay evidence-led, and open to what's next.
Step by Step
Test: Know the Biology Before You Touch It
Standard and functional labs, genetics, and advanced diagnostics should be interpreted as a whole. One number on its own tells you almost nothing, and most care never gets past that.
Personalize: The Average Client Doesn’t Exist
Two people with the same labs can need entirely different plans. Your history, your goals, and the demands of your work decide which one is yours, and I get those by listening.
Prevent: Symptoms Are the Last Thing to Arrive
The risks you can change leave fingerprints in bloodwork years before a diagnosis. Age-based guidelines watch the average. I watch your fault lines.
The Literature Moves. So Do I.
Some of what I see in practice runs ahead of published consensus. When it does, I act on the best available science, and I tell you exactly how solid that ground is.
I Don’t Wait For the Paperwork
You can be early or you can be rigorous, says everyone who's never done both. I'm ahead because I dig deeper.
I wrote my first GLP-1 prescription in 2014, seven years before semaglutide made them a household name, because the data already pointed there.
Ozone, exosomes, and stem cell work are in the same category. I hold them to the same standard, and you'll know how strong the evidence is before any of them touches your plan.
Aging is the laziest diagnosis in medicine. I'm not buying it, and neither should you.